ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 156 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2017. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $354,027,000 | -55.0% | 5,700 | -50.9% | 0.07% | -52.7% |
| Q1 2017 | $786,248,000 | +598.9% | 11,600 | +625.0% | 0.15% | +581.8% |
| Q4 2016 | $112,496,000 | -0.9% | 1,600 | 0.0% | 0.02% | +10.0% |
| Q3 2016 | $113,504,000 | +32.6% | 1,600 | -8.6% | 0.02% | +33.3% |
| Q2 2016 | $85,593,000 | -85.1% | 1,750 | -80.7% | 0.02% | -85.8% |
| Q1 2016 | $572,956,000 | -46.0% | 9,050 | -4.2% | 0.11% | -41.8% |
| Q4 2015 | $1,060,101,000 | +61.9% | 9,450 | +39.0% | 0.18% | +111.6% |
| Q3 2015 | $654,908,000 | -84.4% | 6,800 | -83.4% | 0.09% | -81.5% |
| Q2 2015 | $4,187,751,000 | +64.9% | 40,900 | 0.0% | 0.47% | +65.2% |
| Q1 2015 | $2,539,481,000 | – | 40,900 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |